The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,352.00
Bid: 11,348.00
Ask: 11,350.00
Change: 84.00 (0.75%)
Spread: 2.00 (0.018%)
Open: 11,288.00
High: 11,412.00
Low: 11,288.00
Prev. Close: 11,268.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

23 Mar 2021 13:20

EU does not seek outright vaccine export ban, but wants fair share of jabs, Brussels says

March 23 (Reuters) - The European Union does not aim for a general Covid-19 vaccine export ban but wants to make sure the 27-nation bloc gets its fair share of jabs, the EU Commission said on Tuesday."We are not seeking an outright ban on vaccine ...

Read more
23 Mar 2021 13:19

WRAPUP 4-AstraZeneca to publish full U.S. trial results after rare rebuke over 'outdated' data

(Adds comment from U.S. trial investigator)By Kate Kelland and Julie SteenhuysenLONDON/CHICAGO, March 23 (Reuters) - AstraZeneca will publish up-to-date results from its major U.S. COVID-19 vaccine trial within 48 hours after health officials publi...

Read more
23 Mar 2021 13:19

WRAPUP 3-AstraZeneca to publish full U.S. trial results after rare rebuke over 'outdated' data

(Adds panel comments from Washington Post, researcher comment)By Kate Kelland and Julie SteenhuysenLONDON/CHICAGO, March 23 (Reuters) - AstraZeneca will publish up-to-date results from its major U.S. COVID-19 vaccine trial within 48 hours after hea...

Read more
23 Mar 2021 13:19

WRAPUP 2-AstraZeneca to publish full trial data after U.S. rebuke

LONDON, March 23 (Reuters) - AstraZeneca will publish up-to-date results from its latest COVID-19 vaccine trial within 48 hours after U.S. health officials said the drugmaker's analysis of the shot's efficacy may not have been based on all the av...

Read more
23 Mar 2021 13:19

WRAPUP 1-AstraZeneca to issue trial update after U.S. criticism over data

LONDON, March 23 (Reuters) - AstraZeneca will release the most up-to-date results from its latest COVID-19 vaccine trial within 48 hours after U.S. health officials publicly criticised the drugmaker for using outdated information in a press relea...

Read more
23 Mar 2021 13:12

Tuesday broker round-up

(Sharecast News) - Fevertree: Barclays upgrades to buy with a target price of 2,500p.

Read more
23 Mar 2021 13:00

INSIGHT- In Italy, manslaughter probes worsen vaccine turmoil

By Angelo Amante and Crispian BalmerROME, March 23 (Reuters) - When alarm about potential side effects of AstraZeneca's COVID-19 shot halted vaccinations around Europe this month, many people worried this would damage public trust in the vaccine. ...

Read more
23 Mar 2021 12:56

GLOBAL MARKETS-Oil and shares slide as sanctions, virus fears strike

(Recasts)* U.S., Europe sanctions against China hit shares* Powell to testify from 1600 GMT on U.S. recovery* Oil slides 4% amid demand fears* Global currencies vs. dollar https://tmsnrt.rs/2PmYOcEBy Lawrence White and Alun JohnLONDON/HONG KONG, Marc...

Read more
23 Mar 2021 12:56

GLOBAL MARKETS-Oil and shares slide as sanctions, virus fears strike

(Recasts)* U.S., Europe sanctions against China hit shares* Powell to testify from 1600 GMT on U.S. recovery* Oil slides 4% amid demand fears* Global currencies vs. dollar https://tmsnrt.rs/2PmYOcEBy Lawrence White and Alun JohnLONDON/HONG KONG, Marc...

Read more
23 Mar 2021 12:25

UPDATE: AstraZeneca to post more trial data amid US watchdog pressure

UPDATE: AstraZeneca to post more trial data amid US watchdog pressure

Read more
23 Mar 2021 12:24

UPDATE 1-Back and forth over Astrazeneca's COVID-19 statement an 'unforced error' -Fauci

(Adds Fauci quotes, background)WASHINGTON, March 23 (Reuters) - AstraZeneca Plc's COVID-19 vaccine is likely very good, but an independent review board was concerned about how the drugmaker presented data in a press release this week, top U.S. hea...

Read more
23 Mar 2021 12:17

LONDON MARKET MIDDAY: Stocks down ahead of Powell and Yellen testimony

LONDON MARKET MIDDAY: Stocks down ahead of Powell and Yellen testimony

Read more
23 Mar 2021 11:37

U.S.'s Fauci says Astrazeneca's COVID-19 vaccine likely good, but company statement caused concern

WASHINGTON, March 23 (Reuters) - AstraZeneca Plc's COVID-19 vaccine is likely very good, but an independent review board was concerned about how the drugmaker presented data in a press release this week, top U.S. health official Dr. Anthony Fauci...

Read more
23 Mar 2021 11:21

GLOBAL MARKETS-Shares and oil slide as sanctions, virus fears strike

(Recasts)* U.S., Europe sanctions against China hit shares* Powell to testify on U.S. recovery* Oil slides 4% amid demand fears* European shares slip* Global currencies vs. dollar https://tmsnrt.rs/2PmYOcEBy Lawrence White and Alun JohnLONDON/HONG KO...

Read more
23 Mar 2021 11:03

QUOTES-U.S. health body questions AstraZeneca's COVID-19 vaccine trial data

March 23 (Reuters) - AstraZeneca may have used outdated information in the results of a large-scale COVID-19 vaccine trial, a U.S. health agency said on Tuesday, casting fresh doubt on the efficacy of the shot and its potential U.S. rollout.The s...

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.